<DOC>
	<DOCNO>NCT01523873</DOCNO>
	<brief_summary>The main purpose study prospectively assess general safety profile Dotarem</brief_summary>
	<brief_title>Observational Post-marketing Study Safety Efficacy Dotarem® ( SECURE Study )</brief_title>
	<detailed_description />
	<criteria>patient schedule Dotarem®enhanced MRI patient contraindication MR examination patient contraindication Dotarem® injection per local SPC</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>